DAMGO

CAS: 78123-71-4

Ref. 3D-BD173150

Información del producto

• Nombre: DAMGO
• Sinónimos: Enkephalin, ala(2)-mephe(4)-gly(5)-, (D-Ala(2)-mephe(4)-gly-ol(5))enkephalin, 2-Ala-4-mephe-5-gly-enkephalin, Ala(2)-mephe(4)-gly-ol(5) enkephalin, Dago, Damge, Dagol, Enkephalin, Ala(2)-MePhe(4)-Gly-ol(5)-, Enkephalin, alanyl(2)-methylphenylalanyl(4)-glycine(5)-, Rx 783006, Tyr-ala-gly-(nme)phe-gly-ol, Glyol, L-Phenylalaninamide, L-tyrosyl-D-alanylglycyl-N-(2-hydroxyethyl)-Nalpha-methyl-, L-tyrosyl-D-alanylglycyl-N-(2-hydroxyethyl)-Nalpha-methyl-L-phenylalaninamide
• CAS: 78123-71-4

Descripción

DAMGO is an opioid drug that binds to the δ-opioid receptors in the brain's anterior cingulate cortex. It has a rate constant of 1.7 × 10/M, a high energy metabolism, and significant up-regulation of cyclase activity at doses of 10−8 M. DAMGO also inhibits guanine nucleotide-binding proteins, which are involved in immune responses and the regulation of gene expression. DAMGO may act as a pharmacological agent for infectious diseases such as HIV or bowel disease by binding to toll-like receptor 4 (TLR4) or δ receptors.

• Marca: Biosynth

Propiedades químicas

• Pureza: Min. 95%